跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Lysostaphin
首页
药物
Lysostaphin
Lysostaphin
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
DEIMMUNIZED LYSOSTAPHIN AND METHODS OF USE
EP 3143137 A1
申请人: DARTMOUTH COLLEGE
优先权: 2014
CN
EP
US
WO
11 件公开
Unglycosylated lysostaphin variant protein
US 11155801 B2
申请人: DARTMOUTH COLLEGE
优先权: 2013
CN
US
WO
9 件公开
Compositions and methods for treatment of staphylococcal infection while suppressing formation of antibiotic-resistant strains
US 7078377 B1
申请人: NUTRITION 21 INC
优先权: 2000
US
5 件公开
Method of secretory expression of lysostaphin in Escherichia coli at high level
US 8241901 B2
申请人: HUANG QINGSHAN
优先权: 2005
CN
US
4 件公开
RECOMBINANT POLYPEPTIDE FOR USE AS A MEDICINE, ANTISEPTIC AGENT, ANTIBACTERIAL AGENT, ANTI-INFLAMMATORY AGENT, COMPOSITIONS COMPRISING IT AND USES THEREOF
EP 4041286 C0
申请人: MIEDZYNARODOWY INST BIOLOGII MOLEKULARNEJ I KOMORKOWEJ W WARSZAWIE
优先权: 2019
EP
US
WO
3 件公开
Triple acting antimicrobials that are refractory to resistance development
US 8481289 B2
申请人: DONOVAN DAVID M
优先权: 2009
US
3 件公开
Multimodal Antimicrobial Therapy
US 2015182606 A1
申请人: LONGHORN VACCINES & DIAGNOSTICS LLC
优先权: 2014
US
3 件公开
Antimicrobial agents against Staphylococcus aureus
US 11427812 B2
申请人: LYSANDO AG
优先权: 2016
CN
US
2 件公开
Gargle with complex lysostaphin and its preparation
CN 1173690 C
申请人: SHANGHAI GAOKE BIOENGINEERING
优先权: 2000
CN
2 件公开
Anti-microbial compositions comprising a cationic peptide and a glycylglycine endopeptidase
US 7943128 B2
申请人: UNIV ST ANDREWS
优先权: 2006
US
2 件公开
第 1 / 9 页
上一页
下一页
药物
反馈